Search result for TAKEDA PHARMACEUTICAL CO.
TAKEDA CO. PLANNING TO SELL ITS OTC MEDICINE UNIT TO U.S BLACKSTONE GROUP INC.
Highlights –
- Takeda Co. planning to sell its OTC medicine unit to U.S Blackstone Group Inc.
- Takeda plans on selling the same for around $2.9 billion.
- Takeda aims to reduce its debt of $5.86 billion after its purchase of Shire Plc.